Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) — Healthcare · Share Price, Chart & Market Data
About: Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company has a strategic collaboration with Recipharm Israel Ltd for the development of Lifecycle CDMO Platform. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.74 (+61.62%)
SCNIScinai Immunotherapeutics Ltd
Loading watchlist status…
Trade SCNI now
Scinai Immunotherapeutics Ltd share price
SCNI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:43 am GMT+0
SCNI price performance
31.139%
5D
22.629%
1M
1.028%
YTD
-69.796%
1Y
SCNI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:43 am GMT+0
SCNI details
SCNI Market Signals